The DOI matches its Crossref record; 90 of the 96 references it cites were found in a registry or an index; 79 of the 207 sources its claims cite were checked for support.
Stakeholders' views on the use of psychotropic medication in older people: a systematic review
Open accessAbstract
Background: psychotropic medication use has been shown to increase with age and has been associated with increased risk of falls, strokes and mortality. Various guidelines, regulations and tools have been developed to reduce inappropriate prescribing, but this remains high. In order to understand the reasons for this, we aimed to systematically review healthcare professionals', patients' and family caregivers' attitudes towards the use of psychotropic medication in older people. Methods: a systematic literature search was carried out from inception to September 2020 using PUBMED, EMBASE, PsycINFO and CINAHL and hand-searching of reference lists. Included studies investigated stakeholder views on psychotropic in adults over the age of 65. Findings were thematically synthesised. Results: overall, there was an acceptance of long-term psychotropic medication for older people both living in the community and in residential care. While healthcare professionals were aware of guidelines for the use of benzodiazepines and psychotropic medicines, they identified barriers to following them on individual, team and organisational levels. Alternative non-pharmacological approaches were not always available or accepted by patients. Conclusion: psychotropic medicine use in older adults remains a complex issue, which needs to be addressed on a broad level. Attitudes of older people and healthcare professionals encourage long-term use. Meanwhile, various internal and external factors act as barriers to the use of non-drug alternatives in this population. In order to reduce overprescribing of psychotropics, there is a need to increase the acceptability and accessibility of alternative interventions in both care homes and the community. © 2022 The Author(s).
Overview
CoChat Summary
## TL;DR
This systematic review found broad acceptance of long-term psychotropic medication for older people among older adults, family caregivers, and healthcare professionals, alongside clear barriers to deprescribing and to using non-drug alternatives. The authors conclude that reducing overprescribing will require broader changes, including improving the acceptability and accessibility of alternative interventions in care homes and the community.
## Key findings
- The review included 34 studies and 3,398 stakeholders: 2,712 healthcare and care home staff, 631 older people, and 55 family caregivers.
- Across the included studies, there was acceptance of long-term psychotropic medication in both community and residential care settings.
- Four themes were identified: acceptance of long-term psychotropic medication, risk benefit assessment, best practice versus actual practice, and organisational factors.
- The review reports that psychotropic review interventions reduced prescribing rates by 28–82% in prior studies cited in the discussion.
- Study quality scores ranged from 31% to 100%.
## Methods
- Systematic review of qualitative and descriptive evidence, reported following PRISMA guidance.
- Searched EMBASE, MEDLINE, CINAHL plus, and PsycINFO from inception to September 2020, plus reference lists; included studies on stakeholders’ views about psychotropic use in adults ≥65 years.
- Studies were appraised with the QATSDD tool, and findings were synthesized using thematic synthesis; meta-analysis was not carried out because of heterogeneity in data and study designs.
## Limitations
- The paper states that excluding non-English papers may have excluded useful studies; it also notes that all included studies were from North America, Australia, and Europe.
- The authors say some included studies had “conceptually poor” or “thin” data, which may have limited the thematic synthesis.
- The studies varied greatly in quality; this is stated in the paper, though the authors note themes were consistent across studies.
- Evident from the text: the review did not include the public, only defined stakeholder groups, so broader societal views are not represented.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
36 Valid · 6 Not valid · 30 Not checked · 48 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Despite this, some psychotropics are used far longer than recommended or without appropriate, documented reasons [29–31].”
§ Stakeholders’ views on the use of psychotropic medication in older people: a systematic review > Introduction
What the sources say
- Partly supportedcites [29] Lornstad, 2019, Prevalence and persistent use of psychotropic drugs in older adults receiving domiciliary care at baseline, BMC Geriatr sourceExperimental — accuracy not yet measured
The Results (Persistent use of psychotropic drugs; page unavailable) report high persistent use, and the Discussion (Use of antipsychotics; page unavailable) says antipsychotics should be used only briefly in people with dementia yet were often used at consecutive assessments. The paper does not establish that prescriptions lacked appropriate, documented reasons. (LLM, conf=0.85)
- Not matchedcites [30] Royal College of Psychiatrists
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Partly supportedcites [31] Sgnaolin, 2016, Patterns of chronic benzodiazepine use in the elderly, Arch Clin Psychiatr sourceExperimental — accuracy not yet measured
The Introduction says benzodiazepines should be used short term, and the Discussion concludes that elderly people often use them for long periods. The paper also describes some indications as questionable, but it does not establish that appropriate reasons were absent from medical records; its findings concern benzodiazepines rather than psychotropics generally. (LLM, conf=0.85)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“Due to the diverse nature of this review, heterogenicity of the data and study designs, meta-analyses were not carried out [41].”
§ Stakeholders’ views on the use of psychotropic medication in older people: a systematic review > Methods > Data synthesis
What the sources say
- Could not verifycites [41] Moher, 2009, Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement, BMJ sourceExperimental — accuracy not yet measured
The PRISMA checklist ('The PRISMA statement'; page unavailable) asks authors to describe methods of combining study results 'if done,' but does not say that heterogeneity or diverse study designs prevented a meta-analysis in the citing review. A search for heterogeneity and reasons not to conduct meta-analysis found no passage addressing that decision. (LLM, conf=0.76)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“In older adults, psychotropic use has been associated with the risk of severe adverse effects such as falls [13–18], stroke [17, 19–22] and mortality [13, 23–25].”
§ Stakeholders’ views on the use of psychotropic medication in older people: a systematic review > Introduction
What the sources say
- Partly supportedcites [13] Johnell, 2017, Psychotropic drugs and the risk of fall injuries, hospitalisations and mortality among older adults, Int J Geriatr Psychiatry sourceExperimental — accuracy not yet measured
The Discussion’s Main findings report an association between psychotropic drug use and fall injuries and mortality among older adults. The paper does not report an association with stroke, so it supports only part of the attributed claim. No page number is available in our copy. (LLM, conf=0.88)
- Supportedcites [14] Izza, 2020, Polypharmacy, benzodiazepines, and antidepressants, but not antipsychotics, are associated with increased falls risk in UK care home residents: a prospective multi-Centre study, Eur Geriatr Med source
The citation group attached to this source supports the falls portion of the sentence. In Results > Psychotropic medications and falls, the paper reports that psychotropic medication use was associated with falls among UK care home residents, including after adjustment for age, gender, dementia and number of drugs. (LLM, conf=0.93)
- Not checked — no full text of the sourcecites [15] Seppala, 2018, Fall-risk-increasing drugs: a systematic review and meta-analysis: II. Psychotropics, J Am Med Dir Assoc source
- Supportedcites [16] Janus, 2017, Psychotropic drug-related fall incidents in nursing home residents living in the eastern part of the Netherlands, Drugs R&D source
The citation to this paper supports the falls portion of the sentence, not the separately cited stroke and mortality portions. The Discussion reports an association between several psychotropic drug classes and increased fall risk among nursing home residents; the Introduction also reports evidence of this association in older people. (LLM, conf=0.93)
- Partly supportedcites [17] Richardson, 2020, Adverse effects of Z-drugs for sleep disturbance in people living with dementia: a population-based cohort study, BMC Med sourceExperimental — accuracy not yet measured
The Discussion reports increased falls and ischaemic stroke with higher-dose Z-drugs in people with dementia, supporting those examples but not the claim’s broader scope of psychotropic use in older adults generally. The Results report higher mortality against one comparison group but not another, and the Discussion says it found no consistent or clinically significant increase in mortality risk. (LLM, conf=0.89)
- Not checked — no full text of the sourcecites [18] Díaz-Gutiérrez, 2017, Relationship between the use of benzodiazepines and falls in older adults: a systematic review, Maturitas source
- Supportedcites [19] Hsu, 2017, Antipsychotics and the risk of cerebrovascular accident: a systematic review and meta-analysis of observational studies, J Am Med Dir Assoc source
This source is cited for the stroke portion of the sentence, not falls or mortality. The Discussion (p. 5) reports an association between antipsychotic use and increased cerebrovascular accident risk, with greater risk among older adults. Antipsychotics are the class of psychotropic drugs examined here. (LLM, conf=0.93)
- Partly supportedcites [20] Gill, 2005, Atypical antipsychotic drugs and risk of ischaemic stroke: population based retrospective cohort study, BMJ sourceExperimental — accuracy not yet measured
The Introduction and Additional information sections report concerns and clinical-trial evidence suggesting an association between atypical antipsychotics and stroke in older adults with behavioural and psychological symptoms of dementia. That supports the stroke portion of the citing sentence, but not its broader reference to psychotropic use in older adults generally. The paper's own Results compare atypical with typical antipsychotics and find no significant difference in stroke risk. (LLM, conf=0.83)
- Supportedcites [21] Zivkovic, 2019, Antipsychotic drug use and risk of stroke and myocardial infarction: a systematic review and meta-analysis, BMC Psychiatry source
This source is cited for stroke, not for falls or mortality. Its Results (Antipsychotic drug use and stroke risk; page unavailable) report an association between antipsychotic use and stroke in cohort studies of people with dementia, whose mean ages ranged from 78 to 81 years. Antipsychotics are a type of psychotropic drug. (LLM, conf=0.88)
- Partly supportedcites [22] Szmulewicz, 2017, Long-term antipsychotic use and major cardiovascular events: a retrospective cohort study, J Clin Psychiatry sourceExperimental — accuracy not yet measured
The Clinical Points section associates antipsychotic treatment with higher all-cause mortality in older adults, and the Discussion reports an enhanced risk of stroke in the study population. The paper does not establish a risk of falls, and its findings concern antipsychotics rather than psychotropic drugs generally. (LLM, conf=0.86)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Older adults show greater sensitivity to drugs acting upon the central nervous system and their side effects [11, 12].”
§ Stakeholders’ views on the use of psychotropic medication in older people: a systematic review > Introduction
What the sources say
- Not checked — no full text of the sourcecites [11] Shi, 2008, The clinical implications of ageing for rational drug therapy, Eur J Clin Pharmacol source
- Supportedcites [12] Varma, 2010, The geriatric population and psychiatric medication, Mens Sana Monogr source
The Pharmacodynamic Changes with Age section reports heightened responses to benzodiazepines and anticholinergic agents in older adults. Its Antipsychotic medications subsection also says older adults experience more adverse reactions to antipsychotics than younger people. These passages support the broad claim about sensitivity to centrally acting drugs and their side effects; page numbers are not provided in our copy. (LLM, conf=0.88)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Both doctors and patients shared the belief that older people were largely ‘set in their ways’ [55, 56, 82].”
§ Stakeholders’ views on the use of psychotropic medication in older people: a systematic review > Acceptance of long-term use of psychotropic medication in older people Ageing was seen as a negative experience by many participants; being commonly associated with social, physical and emotional decline such as ill-health, loss of autonomy and bereavement [50, 56, 74, 82]. Both doctors and patients shared the belief that older people were largely ‘set in their ways’ [55, 56, 82]. Doctors anticipated resistance to discontinuation of psychotropic medication or introduction of non-pharmacological interventions and older patients expressed the view that they did not wish to ‘experiment’ at their age by tapering or discontinuing their psychotropic medication [54–56, 59]. Doctors indicated that they did not necessarily agree with or promote long-term use in; however, they discussed being more tolerant of long-term use in older people [54, 56, 59]. Both doctors and older people expressed the view that psychotropic medication was at times used as a ‘crutch’, where taking the medication, even at a very low dose, provided emotional comfort and helped keep the patient on an ‘even keel’ [56, 74]. Family caregivers, nursing staff and doctors all expressed fear of threatening older people’s stable condition. Negative effects experienced by patients during prior attempts to discontinue were also reported to discourage further attempts [54–56, 74]. Doctors expressed being much more careful initiating psychotropic treatment compared to providing repeats for long-term use [59, 81, 82]. Meanwhile, patients were of the view that they trusted prescribers and had confidence in them that if they prescribed medication it was appropriate for them [55, 56, 74]. However, family caregivers had a differing view to other stakeholders in this area and did not always feel that their concerns were listened to by healthcare professionals [51, 65].
What the sources say
- Partly supportedcites [55] Cook, 2007, Older patient perspectives on long-term anxiolytic benzodiazepine use and discontinuation: a qualitative study, Soc Gen Intern Med sourceExperimental — accuracy not yet measured
The Discussion reports that most patients and physicians believed withdrawal from long-term benzodiazepines would be time-consuming and likely futile. That supports a shared pessimism about changing this particular practice, but not the broader belief that older people are generally ‘set in their ways.’ The Discussion also notes that some patients were willing to consider discontinuation despite physicians’ expectations of resistance; page numbers are unavailable in our copy. (LLM, conf=0.85)
- Partly supportedcites [56] Dickinson, 2010, Long-term prescribing of antidepressants in the older population: a qualitative study, Br J Gen Pract sourceExperimental — accuracy not yet measured
In “Barriers to discontinuation of antidepressants” (p. 7), patients say they are too old to change their medication, and GPs express reluctance to disrupt stable treatment. This supports a shared preference for maintaining antidepressant treatment, but not the broader belief that older people are generally ‘set in their ways.’ (LLM, conf=0.82)
- Not checked — no full text of the sourcecites [82] Damestoy, 1999, Prescribing psychotropic medication for elderly patients: some physicians' perspectives, CMAJ
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
36 more claims · 10 with their cited sources checked
Create a free account to see all 120 claims and to verify the 4 references still open.
- Probably not a substantial claim. 61
- It may state two separate claims as one. 37
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Rated major: it would touch a result — a value a result rests on, reported and recomputed p-values on opposite sides of the significance level, two passages that conflict with no sign which is right, or a cited work retracted before this paper was published.
In the paper
“Eighteen quantitative studies, 16 qualitative studies and 2 mixed-method studies were included in this review.”
§ Stakeholders’ views on the use of psychotropic medication in older people: a systematic review > Results > Study characteristics
Reported 34 · recomputed 36
Citations
Cites
Using thematic analysis in psychology
Braun, V., & Clarke, V. (2006) · Qualitative Research in Psychology · doi:10.1191/1478088706qp063oa · Cited by 194,414
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
Methods for the thematic synthesis of qualitative research in systematic reviews
Thomas, J., & Harden, A. (2008) · BMC Medical Research Methodology · doi:10.1186/1471-2288-8-45 · Cited by 9,312
By the 2019 American Geriatrics Society Beers Criteria® Update Expert Panel (2019) · Journal of the American Geriatrics Society · doi:10.1111/jgs.15767 · Cited by 3,163
STOPP/START criteria for potentially inappropriate prescribing in older people: version 2
O'Mahony, D., O'Sullivan, D., Byrne, S., O'Connor, M. N., Ryan, C., & Gallagher, P. (2014) · Age and Ageing · doi:10.1093/ageing/afu145 · Cited by 2,397
Schneider, L. S., Dagerman, K. S., & Insel, P. (2005) · JAMA · doi:10.1001/jama.294.15.1934 · Cited by 1,671
Morrison, A., Polisena, J., Husereau, D., Moulton, K., Clark, M., Fiander, M., Mierzwinski-Urban, M., Clifford, T., Hutton, B., & Rabb, D. (2012) · International Journal of Technology Assessment in Health Care · doi:10.1017/s0266462312000086 · Cited by 1,257
Reviewing studies with diverse designs: the development and evaluation of a new tool
Sirriyeh, R., Lawton, R., Gardner, P., & Armitage, G. (2012) · Journal of Evaluation in Clinical Practice · doi:10.1111/j.1365-2753.2011.01662.x · Cited by 715 · cited 1×
“The 16-item Quality Assessment Tool for Studies with Diverse Designs (QATSDD) tool was used to appraise the studies, as it could uniformly assess and compare the included studies irrespective of their study design [45].”
MethodTannenbaum, C., Martin, P., Tamblyn, R., Benedetti, A., & Ahmed, S. (2014) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2014.949 · Cited by 665 · cited 1×
“Examples include the Halting Antipsychotic Use in Long-Term (HALT) study [36], Eliminating Medications Through Patient Ownership of End Results (EMPOWER) study [37] or Reducing Use of Sedatives (RedUSe) project [38].”
BackgroundMaust, D. T., Kim, H. M., Seyfried, L. S., Chiang, C., Kavanagh, J., Schneider, L. S., & Kales, H. C. (2015) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.3018 · Cited by 617
Research works printed but not linked: 8
- National Institute for Health and Care Excellence (NICE), First-Choice Antidepressant Use in Adults with Depression or Generalised Anxiety Disorder Key Therapeutic Topic [KTT8]
- National Institute for Health and Care Excellence (NICE), Antipsychotics in People Living with Dementia [KTT7]
- National Institute for Health and Care Excellence (NICE), Dementia: Assessment, Management and Support for People Living with Dementia and Their Carers NICE Guidance [NG97]
- Royal College of Psychiatrists, National Audit of Dementia: Prescription of Psychotropic Medication Initiated in Hospital for Behavioural and Psychological Symptoms of Dementia
- Commissioning for Quality and Innovation (CQUIN), CCG7: Three High Impact Actions to Prevent Hospital Falls
- New South Wales Therapeutic Advisory Group, DeprescribingTools
- National Institute for Health and Care Excellence (NICE), Older People: Independence and Mental Wellbeing NICE Guideline [NG32]
- Noyes, Chapter 21: Qualitative Evidence
Cited by
Ngcobo, N. N. (2025) · Clinical Pharmacokinetics · doi:10.1007/s40262-024-01466-0 · Cited by 199
Lukačišinová, A., Reissigová, J., Hadžiabdić, M. O., Brkić, J., Okuyan, B., Volmer, D., Tadić, I., Modamio, P., Mariño, E. L., Tachkov, K., et al. (2024) · BMC Geriatrics · doi:10.1186/s12877-024-04742-7 · Cited by 58
Carrasco‐Garrido, P., Fernández‐de‐las‐Peñas, C., Hernández‐Barrera, V., Palacios‐Ceña, D., Jiménez‐Trujillo, I., & Gallardo-Pino, C. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.975930 · Cited by 23
Harris, D. A., Maclagan, L. C., Pequeno, P., Iaboni, A., Austin, P. C., Rosella, L. C., Guan, J., Maxwell, C. J., & Bronskill, S. E. (2023) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2023.01.022 · Cited by 7
Rantsi, M., Kortelainen, L., Hyttinen, V., Jyrkkä, J., & Kankaanpää, E. (2023) · Age and Ageing · doi:10.1093/ageing/afad094 · Cited by 3
Metadata
- Authors
- Bednarczyk, E., Cook, S., Brauer, R., & Garfield, S.
- Affiliations
- UCL School of Pharmacy (GB)
- London School of Hygiene & Tropical Medicine (GB)
- Imperial College Healthcare NHS Trust (GB)
- Corresponding author
- Bednarczyk, Eliza
- Venue
- Age and Ageing
- Publisher
- Oxford University Press (OUP)
- Published
- 2022-03-01
- Volume
- 51
- Issue
- 3
- ISSN
- 0002-0729 (ISSN-L)
- 1468-2834
- PMC
- PMC8934150
- OpenAlex
- W4214868182
- Cited by
- 22
- References
- 96
- Citations by year
- 2026: 3 · 2025: 6 · 2024: 9 · 2023: 2 · 2022: 2
- FWCI
- 0.68
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Age and Ageing (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Spiral (Imperial College London) (submittedVersion, other-oa)
- Funders
- National Institute for Health and Care Research
- Topics
- Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
- Health Sciences › Medicine › Geriatrics and Gerontology › Geriatric Care and Nursing Homes
- Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
- Keywords
- psychotropic drugs, older adults, inappropriate prescribing, benzodiazepines, stakeholder attitudes, healthcare workers, patients, family caregivers, non-pharmacological treatment, residential care, community-dwelling older adults, chronic drug administration
- MeSH terms
- Accidental Falls, Aged, Health Personnel, Humans, Psychotropic Drugs, Caregivers
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Stakeholders' views on the use of psychotropic medication in older people: a systematic review. https://app.cochat.ai/papers/10.1093/ageing/afac060
- The paper
- Bednarczyk, E., Cook, S., Brauer, R., & Garfield, S. (2022). Stakeholders' views on the use of psychotropic medication in older people: a systematic review. Age and Ageing. https://doi.org/10.1093/ageing/afac060
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
![Figure 1 Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) flow diagram [41].](https://figures.cochat.ai/paper-figures/a7eebc3ab5724dd3be665065f765e30d/stakeholders-views-on-the-use-of-psychotropic-medication-in-older-people-a-figure-1.jpg)